These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 2718286)

  • 1. [Arterial hypertension and fatty acids of the blood in patients with chronic glomerulonephritis without the nephrotic syndrome].
    Neverov NI; Kozlova RI; Mukhin NA
    Urol Nefrol (Mosk); 1989; (1):59-63. PubMed ID: 2718286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Arterial hypertension in patients on chronic hemodialysis].
    Zogović J; Mladenović Lj
    Srp Arh Celok Lek; 1996; 124(9-10):246-50. PubMed ID: 9102857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [On the lipid and fatty acid composition of the blood serum in subjects with glomerulonephrits with the nephrotic syndrome].
    Pisano L; Lombardi D; Spanò G
    Boll Soc Ital Cardiol; 1967; 12(1):27-36. PubMed ID: 5596746
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of fatty acid contents of erythrocyte membrane in hemodialysis and peritoneal dialysis patients.
    An WS; Kim SE; Kim KH; Lee S; Park Y; Kim HJ; Vaziri ND
    J Ren Nutr; 2009 Jul; 19(4):267-74. PubMed ID: 19539181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of lipoic acid, biotin and pyridoxine on blood content of saturated and unsaturated fatty acids in ischemic heart disease and hypertension].
    Vodoevich VP
    Vopr Pitan; 1983; (5):14-6. PubMed ID: 6415917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Omega-3 polyunsaturated fatty acid supplements and ambulatory blood pressure monitoring parameters in patients with mild essential hypertension.
    Russo C; Olivieri O; Girelli D; Azzini M; Stanzial AM; Guarini P; Friso S; De Franceschi L; Corrocher R
    J Hypertens; 1995 Dec; 13(12 Pt 2):1823-6. PubMed ID: 8903660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Functional status of the hemostatic and fibrinolytic systems in patients with clinical variants of chronic glomerulonephritis].
    Miagkov II; Nazar PS
    Ter Arkh; 1989; 61(11):123-6. PubMed ID: 2633374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The kallikrein-kinin, coagulation and fibrinolytic systems of the blood in patients with chronic glomerulonephritis and the hypertension syndrome].
    Nazar PS; Cherniavskaia GF
    Vrach Delo; 1989 Aug; (8):6-8. PubMed ID: 2588532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of lipid and fatty acid metabolism between minimal change nephrotic syndrome and membranous nephropathy.
    Fujita T; Nakamura N; Kumasaka R; Shimada M; Murakami R; Osawa H; Yamabe H; Okumura K
    In Vivo; 2006; 20(6B):891-3. PubMed ID: 17203785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Symptomatic arterial hypertension in lupus nephropathy].
    Gavrilov G
    Vutr Boles; 1979; 18(1):64-9. PubMed ID: 433252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinico-morphological comparisons in patients with chronic glomerulonephritis and elevated arterial pressure].
    Gadaev AG; Akimova SL
    Urol Nefrol (Mosk); 1993; (5):33-6. PubMed ID: 8310582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A follow up study of adult nephrotic syndrome in Nigerians: outcome and predictors of endstage renal failure.
    Ojogwu LI; Ukoli FA
    Afr J Med Med Sci; 1993 Jun; 22(2):43-50. PubMed ID: 7839896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Changes in the fatty acid composition of erythrocyte and platelet membranes after diet therapy in patients with hyperlipoproteinemia type II].
    Korf II; Meshcheriakova VA; Samsonov MA; Chepurnenko NV; Koshechkin VA
    Vopr Med Khim; 1987; 33(3):73-7. PubMed ID: 3630021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hypotensive therapy and the level of blood lipids in patients with chronic nephritis associated with arterial hypertension].
    Neverov NI; Kozlova RI; Vinogradova IV; Galstian GM; Shatskaia OB
    Ter Arkh; 1989; 61(6):123-6. PubMed ID: 2799697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormalities of erythrocyte membrane fatty acid composition in human essential hypertension.
    Ollerenshaw JD; Heagerty AM; Bing RF; Swales JD
    J Hum Hypertens; 1987 Jun; 1(1):9-12. PubMed ID: 3508198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of antiatherosclerotic diet, containing polyunsaturated fatty acids of the omega-3 family from flax oil, on fatty acid composition of cell membranes of patients with ischemic heart disease. Hypertensive disease and hyperlipoproteinemia].
    Rozanova IA; Pogozheva AV; Kupakova SN; Lupinovich VL; Karagodina ZV; Levachev MM; Samsonov MA
    Vopr Pitan; 1997; (5):15-7. PubMed ID: 9460845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of changes in erythrocyte and platelet phospholipid and fatty acid composition and protein oxidation in chronic obstructive pulmonary disease and asthma.
    De Castro J; Hernández-Hernández A; Rodríguez MC; Sardina JL; Llanillo M; Sánchez-Yagüe J
    Platelets; 2007 Feb; 18(1):43-51. PubMed ID: 17365853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The prognostic significance of the morphological and clinical characteristics of chronic glomerulonephritis].
    Riabov SI; Stavskaia VV
    Ter Arkh; 1990; 62(6):27-34. PubMed ID: 2218921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical vitamin B6 deficiency in adults with chronic glomerulonephritides with and without the nephrotic syndrome.
    Labadarios D; Shephard GS; Mineur LG; Van Buuren AJ; Hutchison ME; Oosthuizen OJ
    Int J Vitam Nutr Res; 1984; 54(4):313-9. PubMed ID: 6526596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Lipiduria in the nephrotic syndrome].
    Neverov NI; Nikitina EA
    Ter Arkh; 1992; 64(6):16-8. PubMed ID: 1440328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.